Lucid Diagnostics (LUCD) Capital Expenditures (2021 - 2026)

Lucid Diagnostics has reported Capital Expenditures for 6 years, with the latest figure at $215000.0 in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 131.18% year-over-year to $215000.0; the trailing twelve-month figure through Mar 2026 stood at $319000.0 (down 9.38% YoY), and the FY2025 full-year result was $197000.0, down 33.45% from the prior year.
• Capital Expenditures for Q1 2026 stood at $215000.0, up from $51000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $2.1 million in Q2 2022, with the low at -$1.5 million in Q3 2022.
• Historically, Capital Expenditures has averaged $122466.7 across 5 years, with a median of $51000.0 in 2025.
• The largest YoY upside for Capital Expenditures was 205100.0% in 2022 against a maximum downside of 5439.29% in 2022.
• Lucid Diagnostics' Capital Expenditures stood at $203000.0 in 2022, then dropped by 13.79% to $175000.0 in 2023, then surged by 48.0% to $259000.0 in 2024, then slumped by 80.31% to $51000.0 in 2025, then jumped by 321.57% to $215000.0 in 2026.
• The last three Capital Expenditures figures came in at $215000.0 (Q1 2026), $51000.0 (Q4 2025), and $28000.0 (Q3 2025), per Business Quant data.